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Toxoplasma gondii poses a great threat to human health, with no approved vaccine
available for the treatment of T. gondii infection. T. gondii infections are not limited to
the brain, and may also affect other organs especially the liver. Identification of host
liver molecules or pathways involved in T. gondii replication process may lead to the
discovery of novel anti-T. gondii targets. Here, we analyzed the metabolic profile of the
liver of mice on 11 and 30 days postinfection (dpi) with type II T. gondii Pru strain. Global
metabolomics using liquid chromatography-tandem mass spectrometry (LC-MS/MS)
identified 389 significant metabolites from acutely infectedmice; and 368 from chronically
infected mice, when compared with control mice. Multivariate statistical analysis revealed
distinct metabolic signatures from acutely infected, chronically infected and control mice.
Infection influenced several metabolic processes, in particular those for lipids and amino
acids. Metabolic pathways, such as steroid hormone biosynthesis, primary bile acid
biosynthesis, bile secretion, and biosynthesis of unsaturated fatty acids were perturbed
during the whole infection process, particularly during the acute stage of infection. The
present results provide insight into hepatic metabolic changes that occur in BALB/c mice
during acute and chronic T. gondii infection.
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INTRODUCTION
Toxoplasma gondii infection poses a serious health problem worldwide (Dubey, 2008; Elsheikha,
2008; Dupont et al., 2012). This parasite has a complex life cycle that involves both sexual and
asexual phases. Sexual reproduction results in the formation and shedding of the oocysts by the
felid definitive host (Sullivan and Jeffers, 2012). Ingestion of food or drinking water contaminated
with oocysts is one of the most important sources of infection (Dubey and Beattie, 1988).
Asexual reproduction results in the formation of tachyzoites and bradyzoites-containing tissue
cysts, marking acute and chronic infection, respectively (Munoz et al., 2011; Sullivan and Jeffers,
2012). The transformation of tachyzoites into tissue cysts is immune-mediated and leads to the
establishment of latent infection (Dubey and Frenkel, 1976). Ingesting undercooked or raw meat
that contains tissue cysts is another important source of infection (Dubey and Beattie, 1988).
Although the brain and spinal cord are the primarly affected organs (Elsheikha and Zhu, 2016),
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T. gondii infections are not limited to the central nervous
system, and may also affect other organs. Several hepatic
abnormalities, including hepatomegaly, hepatitis, granuloma,
necrosis, cholestatic jaundice, cirrosis, and abnormalities in liver
enzymes have been observed in the context of T. gondii infection
(Vischer et al., 1967; Weitberg et al., 1979; Wendum et al., 2002).
However, the definite pathophysiological links between T. gondii
and extraneural manifestations are yet to be established.
The association between T. gondii infection and hepatic
injury has attracted considerable attention due to the significant
roles played by the liver in maintaining many body functions.
The mechanisms leading to hepato-pathologic disturbances
in T. gondii-infected mice have been investigated using
transcriptomics (He et al., 2016a) and proteomics (He et al.,
2016b). However, the mechanisms underlying the hepatic
pathological outcomes of T. gondii infection remain unuclear.
T. gondii, a strict intracellular parasite, relies on host cells to
obtain its energetic and nutritional needs (Kafsack and Llinas,
2010). The parasite utilizes essential nutrients from the host cell,
including tryptophan (Pfefferkorn, 1984; Dai et al., 1994; Naemat
et al., 2016); arginine (Fox et al., 2004); polyamines (Seabra et al.,
2004); purines (Schwartzman and Pfefferkorn, 1982; Chaudhary
et al., 2004); cholesterol (Coppens et al., 2000; Coppens and
Joiner, 2003) and other nutrients (Dimier and Bout, 1998;
Charron and Sibley, 2002). Hence, it is reasonable to assume
that infected cells display different metabolic phenotypes, and
that the metabolomic alterations and associated dysregulation of
biochemical pathways may underlie the hepatopathy observed in
toxoplasmosis.
In recent years, transcriptomics and proteomics approaches
have been employed to study the interaction between T. gondii
and its host (Nelson et al., 2008; Pittman et al., 2014; He et al.,
2016a,b; Cong et al., 2017). Metabolomics is a rapidly emerging
field of “omics” research and can provide a global analysis of the
metabolic changes in biological systems in response to external
stimuli or perturbation (Nicholson et al., 1999; Yang et al., 2006;
Holmes et al., 2008). Metabolomics has been as a powerful
method to profile metabolic alterations associated with microbial
infections (Antunes et al., 2011; Shin et al., 2011; Nguyen et al.,
2015). In previous studies, we characterized the metabolomic
profiles of the brain (Zhou et al., 2015), serum (Zhou et al.,
2016), and spleen (Chen et al., 2017) of mice infected with T.
gondii. In this study, we extended our metabolomics analysis to
include the liver due to its important role in maintaining many
metabolic processes in the body. Here, the liver metabolic profile
was compared between mice with acute infection and mice with
chronic infection using liquid chromatography-tandem mass
spectrometry (LC-MS/MS). This approach revealed metabolic
differences between infected and uninfected mice, and between
acutely infected and chronically infected mice.
MATERIALS AND METHODS
Ethical Approval
All experiments were approved by the Animal Administration
and Ethics Committee of Lanzhou Veterinary Research
Institute, Chinese Academy of Agricultural Sciences (Permit No.
LVRIAEC2016-007). Mice were handled in strict accordance
with good laboratory animal practice according to the Animal
Ethics Procedures and Guidelines of the People’s Republic of
China. All efforts were made to minimize animal suffering and
to minimize the number of animals used in the experiments.
Mice Infection
Thirty-nine, 6-week-old, female, BALB/c mice were obtained
from the Laboratory Animal Center of Lanzhou Veterinary
Research Institute, Chinese Academy of Agricultural Sciences.
Mice were housed inmicroisolator cages under specific-pathogen
free (SPF) conditions, with controlled temperature (22 ± 2◦C)
and 12 h light/dark cycles, and were given water and standard
food pellets ad libitum. Mice were randomly allocated into three
groups: acutely infected group (n = 13), chronically infected
group (n = 13) and healthy uninfected group (n = 13). Each
mouse in the infected group was infected orally with 10 tissue
cysts of T. gondii type II Pru strain that were isolated from mice
brain 40 days postinfection (dpi) in 100 µl phosphate buffered
saline solution (PBS). Control mice were gavaged with 100 µl
PBS only. All mice were observed daily for the development of
clinical signs and for survival throughout the entire experiment.
Also, weight loss was monitored as a sign of morbidity.
Collection of Tissues and Characterization
of Infection
At 11 days postinfection (dpi), 10 mice from the acutely infected
group were sacrificed and their livers were collected. A further 10
mice representing chronically infected group, and 10 uninfected
controls, were sacrificed and their livers were collected at 30
dpi. Mice were anesthetized by isoflurane inhalation and then
sacrificed by exsanguination via cardiac puncture. Livers were
rapidly removed, cut into small pieces, rinsed with saline solution
(0.9% NaCl w/v), snap-frozen in liquid nitrogen, and stored
at −80◦C. Mice brain collected at 30 dpi were checked for
the presence of T. gondii cysts using a light microscope. Other
organs (including heart, lung, muscle, small intestine and kidney)
were examined for the presence of T. gondii, as previously
described (Hill et al., 2006). Briefly, total genomic DNA was
extracted from these various tissues using QIAamp R© DNA Mini
kit in accordance with themanufacturer’s instructions (QIAGEN,
Germany). Isolated DNA was then used as a template for PCR
amplification of the T. gondii B1 gene using the specific primers
(5
′
-AACGGG CGA GTA GCA CCT GAG GAG-3′ and 5′-TGG
GTC TAC GTC GAT GGC ATG ACA AC-3
′
). Positive control
(DNA from T. gondii) and negative (deionized water) control
samples were included in each PCR run. Sections of livers from 9
mice (3 from each of the acutely infected, chronically infected,
and control groups) were collected and processed for routine
histopathological examination. Tissues were fixed by submersion
in 10% neutral buffered formalin for 1 week, then dehydrated
in a graded series of ethanol and embedded in paraffin wax.
Sections were made (5µm) using a microtome, then stained
with hematoxylin-eosin (H&E) and examined under an optical
microscope (Olympus, Tokyo, Japan).
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Extraction of Metabolites
Liver samples were taken from storage in a −80◦C freezer
and allowed to thaw at 4◦C. The organic protein precipitation
method was used to extract metabolites. Briefly, 25mg tissue
samples were weighed and then pulverized in liquid nitrogen.
Then, 800 µl methanol/water (1:1) solution and 3mm (mean
diameter) steel beads were added to each sample. Using
a TissueLyser bead-mill homogenizer (QIAGEN, Hilden,
Germany), samples were homogenized via vibrating at
60Hz for 5min. Subsequently, samples were centrifuged at
25,000 g for 10min at 4◦C. To evaluate the reproducibility
and stability of the LC-MS/MS system, 200 µl supernatant
of each sample was mixed to generate a pooled quality
control (QC) sample. The supernatant from each sample was
separated and freeze dried. Finally, dried supernatant samples
were reconstituted in deionized water and analyzed by mass
spectrometry.
LC-MS/MS Analysis
An ultra-performance liquid chromatography (UPLC)
system (Waters, USA) was used to perform all analyses.
The Chromatographic separation was achieved using an
ACQUITY UPLC BEH C18 column (100mm ∗ 2.1mm, 1.7µm,
Waters, USA) at a column temperature of 50◦C and flow rate
of 0.4 ml/min, wherein the mobile phase consisted of solvent
A (water + 0.1% formic acid) and solvent B (acetonitrile +
0.1% formic acid). The following gradient elution conditions
were used to elute metabolites: 100% phase A for 0-2min; 0%
to 100% phase B for ∼11min; 100% phase B for 11–13min;
100% phase A for 13-15min. Injection volume per sample
was 10 µl. The metabolites eluted from the column were
detected using a high-resolution tandem mass spectrometer
SYNAPT G2 XS QTOF (Waters, USA) in positive and negative
electrospray ionization modes. For the positive ionization mode,
the capillary voltage and the cone voltage were set at 2 kV
and 40V, respectively. For the negative ionization mode, these
parameters were set at 1 kV and 40V, respectively. Centroid
MSE mode was used to obtain the mass spectrometry data. The
primary scan ranged from 50 Da to 1200 Da with a scanning time
of 0.2 s. All the parent ionizations were fragmented at 20-40V
and the information from the fragments was collected. During
data acquisition, the LE signal was gained every 3 s for real-time
quality correction. Furthermore, quality control samples (10
samples) were collected in order to evaluate the stability of the
instrument during measurements.
Data Processing and Statistical Analysis
UPLC-MS/MS raw data files were imported into Progenesis QI
software (Waters, UK). Data were processed for possible adducts,
peak alignment, peak detection, deconvolution, dataset filtering,
noise reduction, compound identification, and normalization
with sum method. Chromatograms were aligned to a reference
QC run and selected adducts included [M+H]+, [M+Na]+,
[M+K]+, [M+NH4]+ for ESI+ and [M−H]−, [M+Cl]− for
ESI– with 2.5 AU filter. Peak picking was set to exclude ions
eluted before 0.5min and after 9min at 1% and 92% organic
solution, respectively. The raw data were normalized using a
global scaling factor to align all injections to a reference run
by adjusting for the quantitative abundance of each detectable
feature, correcting for experimental variation based on deviation
from the median. The results were exported in.CSV format for
further analysis and reporting of selected ions by their accurate
mass and retention time pair. The normalized peak data were
further processed by an in-house software metaX (Wen et al.,
2017). Those features that were detected in less than 50% of
QC samples or 80% of biological samples were removed, and
the remaining peaks with missing values were imputed with
the k-nearest neighbor algorithm to further improve the data
quality. Then, the ions that demonstrated relative standard
deviation (RSD) greater than 30% in QC pools were filtered
out.
Multivariate statistical analyses including Principal
Component Analysis (PCA) and Partial Least Squares-
Discriminant Analysis (PLS-DA) were performed to discriminate
infected mice from control mice. PCA was performed for
outlier detection and batch effects evaluation using the
pre-processed dataset. Supervised PLS-DA was conducted
through metaX to discriminate the different variables
between groups. The condition of p-values obtained from
a two-tailed, Student’s t-test on the normalized peak areas
(q-values) ≤ 0.05 and Fold Change (FC) ≥1.2 or ≤ 0.833,
were taken into consideration during the selection of candidate
metabolites. Log2 FC based on metabolite abundance was
used to demonstrate how the differential abundance of liver
metabolites varied between the mouse groups. Differential
metabolites were identified based on q-values (adjusted
p-values using Benjamini-Hochberg procedure) and false
discovery rate (FDR) of ≤ 0.05, FC ≥ 1.2 or ≤ 0.833, and
variable importance in projection (VIP) score ≥ 1 from the
PLS-DA model. Data were log2-transformed prior to cluster
analysis and the generation of heat-maps using R, to show
distinctions in the metabolic state between infected mice and
controls, and between infected mice at different stages of
infection.
Identification of Metabolites
Metabolite identification was performed by matching the exact
molecular mass data (m/z) of samples with the online KEGG
(www.genome.jp/kegg/) database. A mass error range of 10 ppm
was set to match the compound and obtain a mass accuracy
score (Zhong et al., 2017). Progenesis QI software was used to
match the theoretical isotope distribution in the database, and
obtain the isotopic similarity score of the metabolites. Then, all
the possible compounds corresponding to each parent ion in
the first-order spectrum were theoretically fragmented according
to their molecular structure to obtain the theoretical fragment
ions. The spectra of all theoretical fragment ions together formed
the theoretical secondary spectrum. Then, we set the mass
error range of 10 ppm, and matched the actual secondary
spectrum of the experimental samples with the theoretical
secondary spectrum. Scores of the matching similarity between
the spectra were counted. Finally, the three scores were combined
into total assessment scores, which were used to screen the
metabolites.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 June 2018 | Volume 8 | Article 189
Chen et al. Hepatic Metabolomics of Mice During Toxoplasmosis
RESULTS
Clinical and Histopathological Analysis
Infectedmice exhibited a time-dependent increase in progression
of disease. At 7 dpi, infected mice developed mild loss of
appetite and ruﬄed hair coat. On day 11 postinfection, clinical
signs had progressed to those typically observed during acute
infection, including anorexia, weight loss, edema and ruﬄed
hair. By day 14 postinfection infected mice began to recover
from acute signs, and by day 30 postinfection all infected mice
had restored their normal physical state and developed chronic
infection. As expected, control mice did not show any clinical
manifestations throughout the experiment. PCR results of all
examined tissues indicated that all infected mice tested positive,
but control mice tested negative. A histopathological study of
liver tissue from all mice was also performed, in order to ascertain
both acute (11 dpi) and chronic (30 dpi) histopathologies.
Notable histological changes were observed in acutely infected
mice, which showed multifocal mononuclear cell aggregations
with numerous vacuolated hepatocytes (Figure 1A). These
changes featured less prominently in chronically infected mice
(Figure 1B). Livers of the control mice showed no gross
histopathological abnormalities (Figure 1C). The original image
of Figures 1A–C are Figures S1–S3, respectively.
Metabolite Profiling of Liver During
T. gondii Infection
To investigate the hepatic metabolic profiles during infection
progression, liver extracts of T. gondii-infected mice and
uninfected mice were analyzed with an UPLC-MS/MS system.
Analysis of the total ion chromatograms (TIC) and PCA score
plots of QC samples demonstrated the high stability, consistency
and reproducibility of chromatographic separation as shown in
Figure S4A (ESI+) and Figure S4B (ESI–). The PCA scores
plot showed that the uninfected mice cluster distinctly to the
right; whereas the infected mice (acutely infected and chronically
infected) cluster slightly to the left without overlapping with
the uninfected mice and QC samples cluster together as shown
in Figure 2A (ESI+) and Figure 2B (ESI–). We also performed
PLS-DA analysis to compare the three different mouse groups,
including the uninfected and infected (acutely infected and
chronically infected) mice, as shown in Figure 2C (ESI+) and
Figure 2D (ESI–). The PLS-DA analysis showed a high degree
of segregation between the various mouse groups in the positive
and negative electrospray ionization modes, further supporting
the reproducibility of the data.
Differential Metabolites During Different
Infection Phases
Differential metabolites were identified on the basis of VIP
≥ 1 in the PLS-DA model and having a q-value <0.05
or a fold-change ≥ 1.2 with high statistical significance (as
shown in Table S1); including differential ion number, and
the identified up-regulated and down-regulated ions between
different experimental groups. In Table S1, we show that
liver metabolic profile in acutely infected mice had the
largest fold change, when compared with controls. As the
infection progressed, the number of differential metabolites
was relatively decreased. Meanwhile, the concentration of
differential metabolites from acutely infected mice changed
more significantly than those from chronically infected mice.
These differential concentrations of metabolites from distinct
groups were used for cluster analysis and generation of heat-
maps, as shown in Figure 3A (ESI+) and Figure 3B (ESI–
). The heat-maps showed distinct differences between the
infected and the control mice, as well as between acutely
infected and chronically infected mice. We identified 389
significant metabolites from acutely infected group vs. control
(Table S2) and 368 from the chronically infected group vs.
control (Table S3). A Venn diagram (Figure 4) shows the
correlation between metabolites according to the infection
phases, with 205 differential metabolites overlapping between the
two infection phases. KEGG analysis identified 51 differential
metabolites from both infection phases linked to metabolic
pathways (Table 1). Further, we randomly identified several
differential metabolites from Table 1, including anandamide,
cholesterol, choli acid, lithocholic acid, L-Thyroxine, oleic acid
and sphinganine (Figures S5–S11), using standard reference
substances obtained from Sigma-Aldrich (St. Louis, USA).
Perturbed Metabolic Pathways During
Different Infection Phases
According to the KEGG database annotations, there were 85
differential metabolites identified from the acutely infected
group vs. control group and 92 differential metabolites from
chronically infected vs. control groups, involved in metabolic
pathways. The most significantly perturbed metabolic pathways
and the number of upregulated and downregulated differentially
abundant metabolites in each perturbed metabolic pathway,
are shown (Figure 5). In the acutely infected phase: the six
most perturbed metabolic pathways were involved in steroid
hormone biosynthesis, primary bile acid biosynthesis, bile
secretion, neuroactive ligand-receptor interaction, ubiquinone
and other terpenoid-quinone biosynthesis, and the biosynthesis
of unsaturated fatty acids (Figure 5A). In the chronically
infected phase: steroid hormone biosynthesis, primary bile
acid biosynthesis, bile secretion, neuroactive ligand-receptor
interaction, biosynthesis of unsaturated fatty acids, and
arachidonic acid (AA) metabolism were the six most perturbed
metabolic pathways (Figure 5B). More metabolites were
perturbed in AA metabolism in the chronically infected phase,
when compared to the acutely infected phase. In the acutely
infected phase, Leukotriene C4 was upregulated, whereas
20-COOH-LB4 and 11,12-DHET involved in AA metabolic
pathway were downregulated. In the chronically infected phase,
Leukotriene C4, 20-COOH-LB4, Prostaglandin E2, Prostacyctin
and 15-OxoETE involved in AA metabolism were upregulated
and only 11,12-DHET was downregulated. These results
indicate that AA metabolism was downregulated during the
acutely infected phase, but upregulated in chronic infection. A
schematic illustration of the AA metabolic pathway is provided
to show specific metabolites dysregulated during each infection
phase (Figure 6). Multiple differentially abundant metabolites
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FIGURE 1 | Histopathological changes in the liver tissues from Toxoplasma gondii-infected mice. Histopathological analysis was conducted on livers from mock- and
T. gondii-infected mice at days 11 and 30 postinfection. Photomicrographs of liver tissue sections stained with hematoxylin and eosin (original magnification, ×100).
(A) Liver section from a mouse on day 11 postinfection. Liver shows multifocal mononuclear cell aggregations (mainly lymphocytes, arrow) with numerous vacuolated
hepatocyte. (B) At 30 dpi, liver shows mild mononuclear cellular infiltration (arrow), increased numbers of Von Kupffer cells besides numerous pyknotic hepatocytes.
(C) Hepatic tissue from mock-infected, control mice shows a normal histological structure.
FIGURE 2 | Multivariate statistical analysis of the data. (A) PCA scores plot of mice livers, including acutely infected (AI), chronically infected (CI) and uninfected control
(Con) compared to quality control (QC) samples in the positive ion mode (ESI+). (B) PCA scores plot of mice livers in the negative ion mode (ESI–). Clear separation
was detected among the different mice groups and in relation to QC samples. (C) Two dimensional PLS-DA score plots of the acutely infected (AI), chronically infected
(CI) and uninfected control (Con) in the positive ion mode (ESI+). (D) Two dimensional PLS-DA score plots of AI, CI and Con in the negative ion mode (ESI–). Each dot
represents one liver sample, projected onto first (horizontal axis) and second (vertical axis) PLS-DA variables. Mice groups are shown in different colors. The black
ellipse indicates the 95% confidence interval.
involved in amino acid metabolism were also observed (Table 2),
indicating that amino acid metabolism is significantly altered
during T. gondii infection. Multiple amino acid metabolic
pathways, such as tyrosine metabolism, arginine and proline
metabolism, tryptophan metabolism, histidine metabolism,
glycine, serine and threonine metabolism, cysteine and
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FIGURE 3 | (A) Heatmaps of the differential metabolites in acutely infected mice (AI) and chronically infected mice (CI) vs. control mice (Con) in the positive ion mode
(ESI+). (B) Heatmaps of the differential metabolites in acutely infected mice (AI) and chronically infected mice (CI) vs. control mice (Con) in the negative ion mode
(ESI–). Red and green colors indicate values above and below the mean, respectively. Black indicates values close to the mean.
FIGURE 4 | A Venn diagram showing the common and unique metabolites
between the acutely and chronically infected mice vs. control. In total, 389
metabolites were found during acute infection vs. control (red); and 368
metabolites were identified in chronically infected mice vs. control (green), 205
of which were shared between the two groups.
methionine metabolism, taurine and hypotaurine metabolism
and glutathione metabolism, were altered in the infection groups.
DISCUSSION
A non-targeted metabolomics-based approach is presented
that enabled the study of liver metabolites and metabolic
pathways during T. gondii infection with the aim of defining
infection-specific and stage-specific metabolic signatures.
This approach revealed 389 and 368 significantly altered
metabolites in acutely infected mice and chronically infected
mice, respectively, vs. control. The decreased number of altered
metabolites during late infection indicates the restoration of
the metabolic state. 205 differential metabolites were common
to both acutely and chronically infected mice, of these 51
differential metabolites were involved in metabolic pathways
(Table 1).
Previous LC-MS metabolomics analysis of mouse brain
detected 60 differentially abundant metabolites at different
stages of T. gondii infection (Zhou et al., 2015). Liquid
chromatography-quadrupole time-of-flight mass spectrometry
(LC-Q-TOF-MS)-based metabolomics analysis identified
79 and 74 differentially abundant metabolites in ESI+
mode and ESI– mode, respectively, in sera of T. gondii-
infected mice compared to controls (Zhou et al., 2016).
LC-MS/MS-based metabolomics analysis of T. gondii-
infected mouse spleen revealed 132 differentially abundant
metabolites (23 metabolites from acutely infected mice and 109
metabolites from chronically infected mice) compared with
control (Chen et al., 2017). This discord between metabolic
phenotyping of T. gondii infected tissues can be attributed
to heterogeneity in host tissue types or to variation in the
experimental conditions and the analytical protocols used in
these studies.
The liver response to infection should be strong enough
to control the parasite and in the meantime restrained
in order to minimize immune-inflammatory pathology.
Achieving this balance between protection against infection and
immunopathology-induced tissue damage is essential in order
to limit liver injury during T. gondii infection. We identified a
number of altered metabolites and metabolic pathways involved
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TABLE 1 | List of the differential metabolites involved in the perturbed metabolic pathways during acute and chronic phases of Toxoplasma gondii infection.
Metabolite Acute infection vs. control Chronic infection vs. control Metabolic pathway
FC q-value VIP FC q-value VIP
Cholesterol 2.83 1.85e-03 1.37 2.39 5.49e-03 1.27 Steroid biosynthesis; Primary bile acid biosynthesis;
Steroid hormone biosynthesis; Hedgehog signaling
pathway; Ovarian steroidogenesis; Aldosterone
synthesis and secretion; Fat digestion and
absorption; Bile secretion; Vitamin digestion and
absorption; Pathways in cancer; Basal cell
carcinoma





2.76 2.07e-02 1.25 2.23 1.07e-02 1.74 Glycerophospholipid metabolism
Taurocholic acid 0.12 3.70e-02 1.19 2.24 4.25e-02 1.30 Primary bile acid biosynthesis; Taurine and
hypotaurine metabolism; Bile secretion
Dodecanoic acid 3.02 1.91e-02 1.53 3.63 7.78e-03 1.87 Fatty acid biosynthesis
Tetradecanoic acid 1.73 2.04e-03 1.16 1.70 3.62e-03 1.20 Fatty acid biosynthesis
Angiotensin III 0.28 1.56e-03 1.13 0.18 2.66e-04 1.62 Neuroactive ligand-receptor interaction;
Renin-angiotensin system
L-Thyroxine 0.23 4.73e-03 1.19 0.12 5.00e-04 1.71 Tyrosine metabolism; Neuroactive ligand-receptor
interaction; Thyroid hormone synthesis; Thyroid




0.51 2.83e-02 1.08 0.50 2.58e-02 1.19 Tyrosine metabolism
Cholic acid 0.22 6.32e-03 1.13 0.25 1.45e-02 1.60 Primary bile acid biosynthesis; Bile secretion;
Sphinganine 2.11 1.78e-03 1.48 2.86 3.67e-02 1.73 Sphingolipid metabolism; Sphingolipid signaling
pathway
Cortolone 2.72 7.21e-03 1.22 7.21 8.16e-03 2.12 Steroid hormone biosynthesis
Oleic acid 5.76 3.03e-05 2.35 2.73 1.54e-02 1.33 Fatty acid biosynthesis; Biosynthesis of unsaturated
fatty acids
Sphingosine 8.13 3.14e-05 2.64 1.68 1.32e-03 1.11 Sphingolipid metabolism; Sphingolipid signaling
pathway
Erucic acid 2.33 5.74e-04 1.51 1.83 4.63e-03 1.21 Biosynthesis of unsaturated fatty acids
11,12-DHET 0.06 1.82e-04 2.86 0.25 2.84e-02 1.42 Arachidonic acid metabolism; Serotonergic synapse




9.13 1.02e-03 1.67 5.85 1.08e-02 2.57 Primary bile acid biosynthesis
Phytosphingosine 2.06 1.25e-03 1.11 2.10 8.16e-03 1.11 Sphingolipid metabolism
Anandamide 2.24 3.16e-04 1.43 1.92 1.20e-03 1.21 Neuroactive ligand-receptor interaction; Retrograde
endocannabinoid signaling; Inflammatory mediator
regulation of TRP channels
Geranyl-hydroxybenzoate 2.47 5.62e-06 1.43 2.36 2.59e-05 1.53 Ubiquinone and other terpenoid-quinone
biosynthesis
Palmitoleic acid 0.48 1.51e-02 1.10 7.32 1.18e-04 2.36 Fatty acid biosynthesis
Fexofenadine 2.74 5.30e-05 1.90 2.74 5.30e-05 1.90 Bile secretion
Testosterone glucuronide 1.57 3.33e-02 1.38 1.84 1.55e-02 1.69 Steroid hormone biosynthesis
2-Arachidonoylglycerol 4.08 7.26e-06 1.65 3.78 4.05e-02 1.83 Neuroactive ligand-receptor interaction; Retrograde
endocannabinoid signaling
Oleoylethanolamide 0.51 5.64e-03 1.22 13.1 2.80e-03 3.74 cAMP signaling pathway
5beta-Cyprinolsulfate 6.20 4.77e-06 2.70 4.20 5.30e-05 2.19 Primary bile acid biosynthesis
2-Octaprenyl-6
-methoxyphenol
8.15 2.45e-06 1.92 5.81 3.42e-04 1.61 Ubiquinone and other terpenoid-quinone
biosynthesis
Glutathionylspermidine 1.77 8.84e-03 1.21 1.58 3.39e-02 1.01 Glutathione metabolism
(Continued)
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TABLE 1 | Continued
Metabolite Acute infection vs. control Chronic infection vs. control Metabolic pathway
FC q-value VIP FC q-value VIP




2.03 6.38e-04 1.13 3.35 5.75e-03 2.13 Primary bile acid biosynthesis
Lithocholic acid 2.06 4.08e-02 1.40 0.67 1.88e-04 1.01 Bile secretion
20-Hydroxycholesterol 2.31 2.52e-03 1.21 5.90 5.44e-05 2.42 Steroid hormone biosynthesis
7-Dehydrodesmosterol 2.79 4.07e-05 1.68 2.00 2.49e-03 1.21 Steroid biosynthesis
7alpha-Hydroxycholesterol 4.72 3.78e-03 1.90 2.06 8.52e-03 1.26 Primary bile acid biosynthesis
Nervonic acid 11.1 6.37e-05 2.98 6.25 5.38e-04 2.38 Biosynthesis of unsaturated fatty acids
Bradykinin 1.94 1.95e-02 1.62 1.94 2.95e-02 1.59 cGMP-PKG signaling pathway; Sphingolipid
signaling pathway; Neuroactive ligand-receptor
interaction; Complement and coagulation cascades;
Inflammatory mediator regulation of TRP channels;
Regulation of actin cytoskeleton; Chagas disease
(American trypanosomiasis); African
trypanosomiasis; Pathways in cancer




0.33 3.39e-04 1.70 2.65 9.53e-03 1.36 Steroid hormone biosynthesis
Leukotriene C4 3.14 1.46e-02 2.05 3.03 2.19e-02 2.09 Arachidonic acid metabolism; Neuroactive
ligand-receptor interaction; Fc epsilon RI signaling
pathway; Serotonergic synapse; Bile secretion;
Asthma
Delta-Tocotrienol 4.71 2.65e-04 1.64 5.17 4.88e-03 1.58 Ubiquinone and other terpenoid-quinone
biosynthesis
Trypanothione disulfide 2.16 8.94e-03 1.15 2.66 3.34e-03 1.56 Glutathione metabolism
Taurolithocholate sulfate 4.44 1.43e-04 2.17 5.28 1.52e-04 2.49 Bile secretion
Icosadienoic acid 6.03 1.86e-04 1.80 4.26 4.24e-03 1.37 Biosynthesis of unsaturated fatty acids
5”-Phosphoribostamycin 0.18 1.00e-05 2.24 0.32 6.07e-04 1.54 Butirosin and neomycin biosynthesis
Trypanothione 9.45 1.81e-03 3.28 6.21 5.32e-03 2.95 Glutathione metabolism
Docosapentaenoic acid 2.70 1.87e-05 1.30 2.14 1.22e-03 1.02 Biosynthesis of unsaturated fatty acids
Pregnanolone 2.78 5.62e-03 1.16 2.27 1.77e-03 1.15 Steroid hormone biosynthesis
Phospho-anandamide 2.20 5.41e-05 1.12 2.29 1.09e-04 1.28 Retrograde endocannabinoid signaling
13,16-Docosadienoic acid 9.59 1.25e-04 2.58 4.40 1.74e-03 1.83 Biosynthesis of unsaturated fatty acids
Calcitetrol 18.3 1.75e-03 3.62 4.98 3.22e-02 2.43 Steroid biosynthesis
FC, fold change; q-value, adjusted p value calculated by two-tailed Wilcoxon rank-sum tests after false discovery rate correction; VIP, variable importance in projection.
in the inflammatory response to T. gondii infection. Taurine, the
most abundant free amino acid in the liver and other tissues,
has antioxidant and anti-inflammatory activities (Rosa et al.,
2014). Reduced level of taurocholic acid that is involved in
bile acid biosynthesis, taurine and hypotaurine metabolism,
was detected during acute infection, probably to facilitate the
parasite establishment. This taurine-related reduction in the
anti-inflammatory status seemed to be buffered by increased
levels of glutathionylspermidine, trypanothione disulfide and
trypanothione metabolites involved in glutathione (GSH)
metabolism during acute and chronic infections (Silva et al.,
2002; Marino and Boothroyd, 2017). GSH is an important
antioxidant that plays an important role in the defense against
reactive oxygen species produced during oxidative metabolism,
and contributes to DNA repair and protein synthesis (Dringen,
2000; Canugovi et al., 2013). It is important to note that
trypanothione and trypanothione reductase are unique to the
trypanosomatid protozoa (Vincent et al., 2016), as the main
defense mecahnism against oxidative damage (Fiorillo et al.,
2012). Because T. gondii lacks the genes for trypanothione
biosynthesis, it is possible that trypanothione metabolites were
misidentified in the present study. It is also possible that T. gondii
synthesizes trypanosome-specific trypanothione metabolite
using an as yet undiscovered route, but this assumption remains
to be confirmed.
Infection also induced significant changes in levels of
metabolites involved in amino acid metabolism (Table 2).
Tryptophan, tyrosine and arginine are essential amino acids
required by the parasite to sustain its own growth (Silva
et al., 2002; Marino and Boothroyd, 2017). In both acutely
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TABLE 2 | List of the differentially expressed metabolites involved in amino acid metabolism during the acute and chronic phases of Toxoplasma gondii infection.
Metabolites FC q-value VIP CV Metabolic pathways
ACUTELY INFECTED VS. CONTROL
L-Thyroxine 0.23 4.73e-03 1.19 ↓ Tyrosine metabolism
3-Methoxy-4-hydroxyphenylacetaldehyde 0.51 2.83e-02 1.08 ↓
gamma-Glutamyl-gamma-aminobutyraldehyde 2.59 4.45e-03 1.80 ↑ Arginine and proline metabolism
Nopaline 1.84 6.92e-03 1.21 ↑
Indole-3-ethanol 2.17 5.45e-03 1.38 ↑ Tryptophan metabolism
Taurocholate 0.12 3.70e-02 1.20 ↓ Taurine and hypotaurine metabolism
Glutathionylspermidine 1.77 8.84e-03 1.21 ↑ Glutathione metabolism
Trypanothione disulfide 2.16 8.94e-03 1.15 ↑
Trypanothione 9.45 1.81e-03 3.28 ↑
CHRONICALLY INFECTED VS. CONTROL
L-Thyroxine 0.12 5.00e-04 1.71 ↓ Tyrosine metabolism
3-Methoxy-4-hydroxyphenylacetaldehyde 0.50 2.58e-02 1.19 ↓
L-Cystathionine 0.51 2.08e-02 1.21 ↓ Glycine, serine and threonine metabolism; Cysteine and
methionine metabolism
N-Formyl-L-aspartate 0.65 3.73e-04 1.03 ↓ Histidine metabolism
Glutathionylspermidine 1.58 3.39e-02 1.01 ↑ Glutathione metabolism
Trypanothione disulfide 2.66 3.34e-03 1.56 ↑
Trypanothione 6.21 5.32e-03 2.95 ↑
FC, Fold change; q-value, adjusted p value calculated by the two-tailed Wilcoxon rank-sum tests after false discovery rate correction; VIP, variable importance in projection; CV, Content
variance. A single arrow (↑/↓) indicates increased or decreased values compared to the control group.
FIGURE 5 | Statistics and comparison of metabolic pathways during T. gondii infection phases. (A) Metabolic pathways of enriched metabolite ≥ 2 of acutely infected
group vs. control. (B) Metabolic pathways of enriched metabolite ≥ 2 of chronically infected vs. control. Red and green metabolites indicate higher and lower
concentrations, respectively. The x-axis denotes the number of differentially abundant metabolites. The y-axis indicates the name of metabolic pathways. The
percentage represents coverage rate of the pathway, which is the differential metabolites/total metabolites in the pathway.
and chronically infected mice, L-thyroxine and 3-Methoxy-4-
hydroxyphenylacetaldehyde, involved in tyrosine metabolism,
were downregulated. Uniquely in acutely infected mice, indole-
3-ethanol involved in tryptophan metabolism, and gamma-
glutamyl-gamma-aminobutyraldehyde and nopaline involved in
arginine and proline metabolism, were upregulated. This finding
is consistent with our earlier proteomic analysis of mouse liver
infected with T. gondii, where indoleamine 2,3-dioxygenase
(Ido2) was downregulated in the infected livers, probably to
support the parasite growth by countering the reduction in
tryptophan (He et al., 2016b). Dysregulation in the levels of
these amino acids is to be anticipated because this parasite is
auxotrophic for tryptophan and arginine, among other amino
acids.
We previously showed, based on preotomics analysis, that
T. gondii interferes with the metabolism of fatty acids, lipids
and energy in the liver via the modulation of host peroxisome
proliferator-activated receptor (PPAR) signaling pathway (He
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FIGURE 6 | Pathway analysis of arachidonic acid metabolism during acute and chronic infection. A schematic illustration of arachidonic acid metabolism pathway; the
most significant differentially expressed metabolites during acute and chronic infection phases. Red and blue arrows represent upregulated and downregulated
metabolites. The metabolites without arrows are not changed. In the acute infection, Leukotriene C4 (LTC4) was upregulated whereas 20-COOH-LB4 and
11,12-DHET were downregulated; but in the chronic infection, LTC4, 20-COOH-LB4, Prostaglandin E2 (PGE2), Prostacyctin and 15-OxoETE were upregulated with
only 11,12-DHET being downregulated.
et al., 2016b). We also observed notable changes in the
hepatic levels of lipids in infected mice. As shown in Figure 5
and Table 1, in acutely and chronically infected mice, the
major perturbed metabolic pathways included steroid hormone
biosynthesis, primary bile acid biosynthesis, steroid biosynthesis,
biosynthesis of unsaturated fatty acids, fatty acid biosynthesis,
and arachidonic acid metabolism. Downregulation of genes
involved in bile synthesis, and the metabolism of sterol, fatty
acids, and lipids have also been reported (He et al., 2016a). Steroid
hormones contribute to several physiological processes; relevant
to T. gondii infection are the immunoregulatory activities
of steroids, which can influence the host immune response
to infection (Tait et al., 2008). Fatty acids are essential for
the synthesis of membranes of the newly produced parasites
(Ramakrishnan et al., 2012) and lipids have been implicated in
the pathogenesis of T. gondii infection (Milovanovic´ et al., 2017).
Upregulation ofmetabolites involved in sphingolipidmetabolism
was also observed during both phases of infection. Sphingolipids
play critical roles in mediating cell-cell interaction, modulating
the behavior of cellular proteins and receptors, and participate in
signal transduction (Merrill, 2002).
Arachidonic acid (AA) metabolism was the most significant
differentially abundant metabolic pathway between acutely
and chronically infected mice. AA has been shown to promote
T. gondii invasion (Li et al., 2008). The metabolism of AA
was downregulated during acute infection and upregulated
during chronic infection (Figure 6). In response to an
inflammatory stimulus, AA, the main polyunsaturated fatty
acid present in the phospholipid of cell membranes, is released
and metabolized to a series of eicosanoids, including the
inflammatory leukotrienes and prostaglandins (Greene et al.,
2011). AA and its inflammatory metabolites mediate the
regulation of key cellular processes, such as cell survival,
angiogenesis, chemotaxis, mitogenesis, apoptosis and migration
(Rizzo et al., 1999; Levick et al., 2007). Alpha-linolenic acid
(ALA), an essential omega-3 fatty acid that is commonly found
in seeds, nuts, and vegetable oils, was perturbed during chronic
stage of infection. However, because ALA is an essential fatty
acid (i.e., cannot be synthesized by the mice), its increased level
must have been derived from the mouse diet.
Our results showed a stronger impact of the parasite infection
on the liver metabolic status during acute compared to chronic
infection. However, one possible reason for the metabolic
alterations observed during chronic infection may be partly
related to considering 30 dpi as the chronic phase of T. gondii
infection, which is a relatively early time point to mark the
latency of T. gondii infection. In fact, a previous study showed
low parasite burden and absence of parasite DNA in the liver of
Swiss albino mice infected with T. gondii type II Me49 strain at
28 and 42 dpi, respectively (Djurkovic´-Djakovic´ et al., 2012).
CONCLUSION
By taking a global approach to understanding the metabolomics
of mouse liver in the context of T. gondii infection, we have
identified a number of previously known and novel metabolites
that play biological roles relevant to host-parasite interaction.
Our data indicate that mouse liver harbors intrinsic mechanisms
to restrict T. gondii replication. For example, through the
upregulation of GSHmetabolism, liver can buffer oxidative stress
associated with infection. On the other hand, the parasite has
evolved mechanisms to exploit various lipids and amino acids,
to support its own proliferation. Our metabolic profiling also
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showed many altered metabolites and metabolic pathways (e.g.,
steroid hormone biosynthesis, primary bile acid biosynthesis, bile
secretion, and biosynthesis of unsaturated fatty acids) in the liver
of T. gondii-infected mice during acute and chronic infections
when compared with healthy uninfected mice. These findings
provide new insight into metabolic changes that occur in the liver
in acute and chronic murine toxoplasmosis.
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